Quality of life in Prolactinoma: A systematic review
Authors:
Open Access
- 24 April 2024
- journal article
- research article
- Published by Springer Nature in Pituitary
- Vol. 27 (3) , 239-247
Abstract
Background: Prolactinomas are common tumours that significantly reduce quality-of-life (QOL) due to sellar mass effect, secondary hypogonadism, and the peripheral effects of prolactin. Understanding the factors that influence QOL would provide insights into therapeutic targets to optimise patient outcomes and improve wellbeing in prolactinoma. Methods: A systematic review was performed in accordance with the PRISMA statement. Studies that reported patient QoL using validated metrics were included. Bias and methodological rigour were assessed using the MINORS criteria. Results: A total of 18 studies were identified studies were available for review, comprising 877 patients. Most were small cross-sectional studies at high risk of bias. Prolactinoma exhibit worse QOL than healthy controls, particularly mental and psychosocial wellbeing. QOL is also worse than patients with non-functional adenomas, but better than those with Cushing’s disease and acromegaly. QOL correlates with prolactin levels, and approaches population baseline with prolonged biochemical control. Dopamine agonists and surgery both improve overall QOL, however improvements are more rapid with surgery. Conclusion: Poor quality of life in prolactinoma is multifactorial, related to biochemical control, side effects of therapy, and sellar mass effect. Targeting persistent symptoms, reducing healthcare costs, and reducing side-effects of therapy are avenues to improving QOL in patients with prolactinoma.Keywords
Funding Information
- Monash University
This publication has 88 references indexed in Scilit:
- Hyperprolactinemia and bonePituitary, 2020
- The development and validation of the Leiden Bother and Needs Questionnaire for patients with pituitary disease: the LBNQ-PituitaryPituitary, 2016
- Towards a better quality of life (QoL) for patients with pituitary diseases: results from a focus group study exploring QoLPituitary, 2014
- Quality of life in women with microprolactinoma treated with dopamine agonistsPituitary, 2008
- Relationship between high prolactine levels and migraine attacks in patients with microprolactinomaThe Journal of Headache and Pain, 2008
- Pituitary Volume and HeadacheArchives of Neurology, 2004
- Development of the 25-list-item National Eye Institute Visual Function QuestionnaireArchives of Ophthalmology (1950), 2001
- Severe hyperprolactinaemia is associated with decreased insulin binding in vitro and insulin resistance in vivoDiabetologia, 1985
- Prolactin: A diabetogenic hormoneDiabetologia, 1977
- An Inventory for Measuring DepressionArchives of General Psychiatry, 1961